Pharvaris PHVS
NASDAQ PHVS
$35.58 -0.08 (-0.22%)
As of: Sep 4, 2026 · 3:15 PM EDT

Pharvaris (PHVS) Retained Earnings (2019 - 2026)

Pharvaris' (PHVS) quarterly Retained Earnings came in at $61.9 million in Q1 2026, up 36.69% YoY from $45.3 million in Q1 2025, and up 4.8% on a QoQ basis from $59.1 million in Q4 2025.

Analysis

Pharvaris (PHVS) Retained Earnings (2019 - 2026) Analysis & Trends

Pharvaris (PHVS) has 8 years of Retained Earnings data on file, last reported at $61.9 million in Q1 2026.

  • Quarterly Retained Earnings rose 36.69% year-over-year to $61.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.9 million (up 36.69% YoY) and the FY2025 annual result came in at $57.4 million, up 33.45% from the prior year.
  • Retained Earnings climbed to $61.9 million in Q1 2026, from $59.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $61.9 million in Q1 2026 to a low of $13.2 million in Q1 2022.
  • A 5-year average of $35.1 million and a median of $32.4 million in 2024 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2022 — Retained Earnings surged 169.86% — and 2024, when it soared 30.36%.
  • Tracing PHVS's Retained Earnings over 5 years: stood at $20.6 million in 2022, then surged by 45.85% to $30.0 million in 2023, then soared by 41.39% to $42.4 million in 2024, then jumped by 39.26% to $59.1 million in 2025, then climbed by 4.8% to $61.9 million in 2026.
  • The last three Retained Earnings figures came in at $61.9 million (Q1 2026), $59.1 million (Q4 2025), and $55.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 558.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -4.00 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 4.38 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.57 Bn
10 Pharvaris 2.11 Bn 1.74 Bn 85,072.10 -777,128.28 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -777,128.28 Bn
Mar 31, 2026 -725,320.12 Bn
Dec 31, 2025 -674,675.32 Bn
Sep 30, 2025 -622.38 Mn
Jun 30, 2025 -560.26 Mn
Mar 31, 2025 -471.99 Mn
Dec 31, 2024 -429,847.85 Bn
Sep 30, 2024 -402.77 Mn
Jun 30, 2024 -349.74 Mn
Mar 31, 2024 -319.41 Mn
Dec 31, 2023 -286,112.46 Bn
Sep 30, 2023 -253.22 Mn
Jun 30, 2023 -227,436.41 Bn
Mar 31, 2023 -200.56 Mn
Dec 31, 2022 -167,513.28 Bn
Sep 30, 2022 -125.95 Mn
Jun 30, 2022 -124.03 Mn
Mar 31, 2022 -116.27 Mn
Dec 31, 2021 -100,175.71 Bn
Sep 30, 2021 -88.54 Mn